News

Article

Sponsored Content

NGS-Based Viral Safety Testing for ATMPs: Mandatory or Just an Option?

Author(s):

Charles River

NGS-Based Viral Safety Testing for ATMPs: Mandatory or Just an Option?

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Content
Site Logo
September 17th 2025

Industrialize Autologous Therapies

Catalent
Site Logo
September 17th 2025

Ease the burden of managing metabolite identification

SCIEX
Site Logo
September 17th 2025

Pharmaceutical quantitation solution guide

SCIEX
Site Logo
September 17th 2025

Modernizing HPLC: Bridging Legacy Bioseparations Methods with Next-Gen Performance

Waters Corporation
Site Logo
September 17th 2025

Benefits of Wireless Continuous Monitoring Systems

Mesa Labs
Site Logo
September 17th 2025

Bill Hartzell, SVP, Manufacturing and Bioservices, on Emergent’s Unique Strategic Manufacturing Partnerships and the Storied History of Our Winnipeg Site

Emergent
© 2025 MJH Life Sciences

All rights reserved.